Ensuring products are safe across the supply chain
Counterfeit or diverted drugs pose serious harm to patients. They can even be fatal. Statistics show that one million patients die annually from toxic counterfeit pharmaceuticals.
The rising incidence of pharmaceutical counterfeiting ($200B globally) has resulted in varying legislation worldwide to secure global supply chains. End-to-end product tracking and authentication—from point of manufacture to point of dispensation—is essential to ensure compliance, control quality, stop revenue loss and keep people safe. Achieving this level of traceability is not easy.
The world’s leading pharmaceutical companies rely on Systech—the serialisation pioneer—to secure their distribution channels. Systech uniquely combines powerful machine vision with flexible cloud-based solutions into one comprehensive platform to provide complete item transfer visibility from manufacturing through the supply chain into the patient’s hands.
Safeguarding consumers, brand and revenue
Even with worldwide legislation in place, issues such as diversion and serial number replication continue to put patients at risk. Moving beyond serialisation, Systech offers a simple brand-protection solution that works with the customer’s existing drug packaging. There is no need to add special inks, holograms, taggants or any other common authentication technology.
Each physical item becomes connected with a unique digital identifier—or e-Fingerprint—that cannot be reverse engineered or duplicated. This provides non-additive covert product security. With a mobile app, users can instantly confirm that medicines are authentic, check tracking details and exchange information at any point across the supply chain.
Connecting the physical to the digital for blockchain-enabled security
More and more companies are looking at technologies such as blockchain to leverage their new data paradigm and provide a globally distributed immutable record of their data. Distributed systems have no single point of failure and their scalability is huge.
While pharmaceutical trading partners may not be exchanging bitcoins for drug products, there is inherent value in blockchain technology to provide a layer of trust which is missing today. The key elements required to establish cryptocurrency are in line with what is needed to secure the supply chain against product counterfeiting and diversion.
The challenge is taking a purely digital technology and applying it to the physical world. That’s where Systech comes in. Its e-Fingerprint technology provides a seamless and direct digital connectivity path for each item’s unique data and ensures authenticated physical product identity. When combined, these technologies provide the closed loop required for ultimate security and complete trust.
Come and see us at CPhI Worldwide, Madrid, 9-11th October - Hall 4 F126